EUVIMEDEUVIMED entdecken
Crossref

Hyperoside alleviates photoreceptor degeneration by preventing cell senescence through AMPK‐ULK1 signaling

Jia Liang iD, Fei Yao iD, Dong Fang iD, Lu Chen iD, Zhenhua Zou iD, Lujia Feng iD, Yijing Zhuang iD, Ting Xie iD, Pengxue Wei iD, Pengfeng Li iD, Shaochong Zhang iD

The FASEB Journal · 2023

DOI: 10.1096/fj.202301273rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Jia Liang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Eye Hospital, Shenzhen Eye Institute, Jinan University, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Retinal Degeneration. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vision loss and blindness are frequently caused by photoreceptor degeneration, for example in age‐related macular degeneration and retinitis pigmentosa. However, there is no effective medicine to treat these photoreceptor degeneration‐related diseases. Cell senescence is a common phenotype in many diseases; however, few studies have reported whether it occurs in photoreceptor degeneration diseases. Herein, we identified that cell senescence is associated with photoreceptor degeneration induced by N‐methyl‐N‐nitrosourea (MNU, a commonly used photoreceptor degeneration model), presented as increased senescence‐associated β‐galactosidase activity, DNA damage, oxidative stress and inflammation‐related cytokine Interleukin 6 (IL6), and upregulation of cyclin p21 or p16. These results suggested that visual function might be protected using anti‐aging treatment. Furthermore, Hyperoside is reported to help prevent aging in various organs. In this study, we showed that Hyperoside, delivered intravitreally, alleviated photoreceptor cell senescence and ameliorated the functional and morphological degeneration of the retina in vivo and in vitro. Importantly, Hyperoside attenuated the MNU‐induced injury and aging of photoreceptors via AMPK‐ULK1 signaling inhibition. Taken together, our results demonstrated that Hyperoside can prevent MNU‐induced photoreceptor degeneration by inhibiting cell senescence via the AMPK‐ULK1 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesRetinal DegenerationAnimalsApoptosisCellular SenescenceDisease Models, AnimalMethylnitrosoureaPhotoreceptor Cells, VertebrateRetinaQuercetin

Stichwörter der Autor:innen

Hyperosidecell senescencephotoreceptor degeneration

Substanzen

AMP-Activated Protein KinasesMethylnitrosoureahyperosideQuercetin

Autor:innen und Institutionen

  • Shenzhen Eye Hospital, Shenzhen Eye Institute, Jinan University, Shenzhen, Guangdong, China.

ORCID-Profile: Jia Liang, Fei Yao, Dong Fang, Lu Chen, Zhenhua Zou, Lujia Feng, Yijing Zhuang, Ting Xie, Pengxue Wei, Pengfeng Li, Shaochong Zhang

Zitieren

APA

Liang, J., Yao, F., Fang, D., Chen, L., Zou, Z., Feng, L., Zhuang, Y., Xie, T., Wei, P., Li, P., & Zhang, S. (2023). Hyperoside alleviates photoreceptor degeneration by preventing cell senescence through AMPK‐ULK1 signaling. The FASEB Journal. https://doi.org/10.1096/fj.202301273rr

Vancouver

Liang J, Yao F, Fang D, Chen L, Zou Z, Feng L, et al. Hyperoside alleviates photoreceptor degeneration by preventing cell senescence through AMPK‐ULK1 signaling. The FASEB Journal. 2023. doi:10.1096/fj.202301273rr

BibTeX
@article{Liang2023,
  author = {Liang, Jia and Yao, Fei and Fang, Dong and Chen, Lu and Zou, Zhenhua and Feng, Lujia and Zhuang, Yijing and Xie, Ting and Wei, Pengxue and Li, Pengfeng and Zhang, Shaochong},
  title = {Hyperoside alleviates photoreceptor degeneration by preventing cell senescence through AMPK‐ULK1 signaling},
  journal = {The FASEB Journal},
  year = {2023},
  doi = {10.1096/fj.202301273rr}
}
Kostenlos starten →